George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPennant International Regulatory News (PEN)

Share Price Information for Pennant International (PEN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 28.50
Bid: 28.00
Ask: 29.00
Change: 0.00 (0.00%)
Spread: 1.00 (3.571%)
Open: 28.50
High: 28.50
Low: 28.50
Prev. Close: 28.50
PEN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

20 Jan 2022 07:00

RNS Number : 0240Z
Pennant International Group PLC
20 January 2022
 

 

FOR IMMEDIATE RELEASE 20 January 2022

PENNANT INTERNATIONAL GROUP PLC

Trading Update

 

 

Pennant International Group plc (AIM:PEN) ("Pennant", the "Group" or "Company"), a leading global provider of training technology and integrated product support solutions, issues the following trading update for the year ended 31 December 2021 ("FY21"). The Company expects to publish its full-year results during May 2022.

 

A preliminary unaudited assessment of the Group's trading for FY21 indicates:

 

· revenues of circa £16 million;

· loss before interest, taxation and amortisation of circa £0.6 million;

· net debt at year-end of £3.6 million;

· three-year order book at year-end of £22 million, of which £10 million is scheduled for delivery in 2022.

 

As expected, trading improved in the second half of FY21 (with the Group generating positive EBITA of circa £0.4 million for the period 1 July to 31 December) albeit the improvement was lower than budgeted as a result of two material factors, detailed below.

 

MTE Programme

 

The challenges associated with the MTE programme were previously highlighted in the Interim Results announcement of 22 September 2021 (and included supply chain issues, residual Covid impacts, global shortages and engineering complexity).

 

The build of the MTE devices is now largely complete, with customer acceptance testing having commenced in November 2021.

 

The testing process was temporarily paused before year-end, however, testing has now re-commenced, with two of the four training devices scheduled for delivery to site in February 2022.

 

The programme will, accordingly, be marginally extended; management anticipates that all devices will be delivered during the first half of 2022. Delivery of the devices will enable Pennant to invoice remaining cash milestones totalling circa £2 million.

 

In light of this extension, and to ensure the necessary resources to deliver and finally 'close off' this contract, the Board has prudently increased internal programme budgets (including a cost allowance to deal with any remaining risks) which is fully taken into account within the year-end position.

 

Contract award timing

 

Pipeline conversion in the second half of FY21 proceeded in line with the Group's expectations with one exception: a software and services contract with a new customer in the commercial aviation sector was slightly delayed. The contract had been expected to be awarded to Pennant before year-end but will now fall into the current year.

 

The contract is worth USD$1.1 million in the first year (and USD$1.8 million overall); the sale of software licences under the contract had been budgeted to contribute to the Group's performance for FY21. The terms of the contract have now been agreed and it is in the process of being finalised and signed.

 

Commenting on the Outlook for 2022, Pennant Group CEO, Phil Walker said:

 

"2021 was a challenging year for Pennant given the continued impact of the Covid-19 pandemic on our business sector and the wider global economy.

 

"It is therefore pleasing that momentum has started to build again in our core product offerings and pipeline of new business. The Group continues to focus on its strategic objective of increasing the proportion of revenues which derive from software and services which is intended to deliver significant growth over the medium-term.

 

"Bid activity is increasing across the Group, and the Board remains very confident of the award of the 'Major Programme' within the first quarter of the year.

 

"The Group remains well placed to capture the many opportunities which lie ahead and accordingly, the Board views prospects for 2022 with increasing confidence and looks forward to reporting a significantly improved performance for the current year."

 

Certain information contained in this announcement would have constituted inside information (as defined by Article 7 of Regulation (EU) No 596/2014) ("MAR") prior to its release as part of this announcement and is disclosed in accordance with the Company's obligations under Article 17 of MAR.

 

 

Enquiries:

 

Pennant International Group plc

www.pennantplc.co.uk

Philip Walker, CEO

David Clements, Commercial & Risk Director

+44 (0) 1452 714 914

 

 

WH Ireland Limited (Nomad and Broker)

www.whirelandcb.com

Mike Coe

Sarah Mather

+44 (0) 20 7220 1666

 

 

Walbrook PR (Financial PR)

paul.vann@walbrookpr.com

Paul Vann

Tom Cooper

+44 (0)20 7933 8780

Mob: +44 (0)7768 807631

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTBKCBDNBKBADD
Date   Source Headline
24th Apr 20242:44 pmRNSNotice of Results and Appointment of Board Adviser
7th Feb 20247:00 amRNSAppointment of Non-executive Director
7th Feb 20247:00 amRNSYear-End Trading Update
22nd Nov 202311:41 amRNSHolding(s) in Company
15th Nov 20235:20 pmRNSHolding(s) in Company
27th Sep 20237:00 amRNS2023 Interim Results
11th Sep 20237:00 amRNSNew Strategic Partnership
7th Sep 20237:00 amRNSPennant attending DSEI, London
19th Jul 20237:00 amRNSTrading Update & Notice of Interim Results
10th Jul 202310:39 amRNSIssue of Equity, Director Dealings & TVR
13th Jun 20237:00 amRNSBusiness Update: New Contract Wins
7th Jun 202310:40 amRNSResult of AGM
23rd May 202310:45 amRNSHolding in Company
22nd May 20233:15 pmRNSHolding in Company
16th May 202312:21 pmRNSHolding in Company
27th Apr 202311:31 amRNSNotice of AGM & Posting of 2022 Annual Accounts
26th Apr 20237:00 amRNS2022 Final Results
20th Apr 20237:00 amRNSNotice of 2022 Final Results
13th Apr 20237:00 amRNSAcquisition of UK Rail Services Business
16th Mar 20232:00 pmRNSHolding(s) in Company
14th Mar 20235:30 pmRNSHolding(s) in Company
23rd Feb 20231:13 pmRNSAppointment of Chair
8th Feb 202311:05 amRNSSecond Price Monitoring Extn
8th Feb 202311:00 amRNSPrice Monitoring Extension
8th Feb 20237:00 amRNSYear-end Trading Update
19th Jan 20239:31 amRNSHolding(s) in Company
12th Jan 202312:47 pmRNSAppointment of Director
9th Nov 20227:00 amRNSShare Option Restructuring
24th Oct 20228:31 amRNSDirectorate Change
21st Sep 20227:00 amRNS2022 Interim Results
9th Aug 20225:51 pmRNSIssue of Equity, Director/PDMR Dealings & TVR
9th Aug 202210:32 amRNSHoldings in Company
3rd Aug 20227:00 amRNSSale of Pennant Court
28th Jul 20227:00 amRNSTrading Update & Notice of Interim Results
30th Jun 20227:00 amRNSNotice of Capital Markets Day
22nd Jun 202210:27 amRNSResult of AGM
27th May 202210:56 amRNSNotice of AGM
25th May 20227:00 amRNS2021 Final Results
29th Apr 20227:00 amRNSNotice of Final Results
19th Apr 20221:42 pmRNSHolding in Company
6th Apr 20227:00 amRNSIssue of Equity, Director/PDMR Dealings & TVR
23rd Mar 20227:00 amRNSContracts & Order Book Update
21st Jan 202210:19 amRNSMajor Programme Update
20th Jan 20229:05 amRNSSecond Price Monitoring Extn
20th Jan 20229:00 amRNSPrice Monitoring Extension
20th Jan 20227:00 amRNSTrading Update
16th Dec 202110:55 amRNSHolding in Company
3rd Dec 202111:20 amRNSMajor Programme Update
17th Nov 202112:04 pmRNSHolding in Company
11th Nov 20215:13 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.